FBLIM1 mRNA is a novel prognostic biomarker and is associated with immune infiltrates in glioma
Glioma is the most common primary brain tumor. Filamin-binding LIM protein 1 (FBLIM1) has been identified in multiple cancers and is suspected of playing a part in the development of tumors. However, the potential function of FBLIM1 mRNA in glioma has not been investigated. In this study, the clinic...
Main Authors: | Deng Yifan, Zeng Kailiang, Wu Diancheng, Ling Yunzhi, Tian Yu, Zheng Yi, Fang Shumin, Jiang Xiaocong, Zhu Gang, Tu Yanyang |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2023-12-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0863 |
Similar Items
-
MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01) -
CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma
by: Xu Z, et al.
Published: (2023-10-01) -
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
by: Junsheng Li, et al.
Published: (2022-04-01) -
Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
by: Zhi-liang Wang, et al.
Published: (2022-10-01) -
HK3 stimulates immune cell infiltration to promote glioma deterioration
by: Shupeng Li, et al.
Published: (2023-10-01)